CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat©): Modification of perioperative management?

International Journal of Cardiology

Volumn 127, Issue 2, 2008, Pages 257-259

  Boeken, U ^a   Litmathe, J ^a   Kurt, M ^a   Feindt, P ^a   Gams, E ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Antifibrinolytic drugs; Coronary surgery; Postoperative bleeding; Tirofiban

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; FRESH FROZEN PLASMA; HEPARIN; TIROFIBAN; TRANEXAMIC ACID;

ANTICOAGULATION; ARTICLE; BLEEDING; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEMOFILTRATION; HUMAN; INCIDENCE; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; STERNOTOMY; THROMBOCYTE TRANSFUSION; TREATMENT DURATION;

ANTIFIBRINOLYTIC AGENTS; APROTININ; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; HEMOSTATICS; HUMANS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID; TYROSINE;

EID: 44649138485     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.02.062     Document Type: Article

References (13)

1. Dyke C.M. Safety of glycoprotein IIb/IIIa inhibitors: a heart surgeon's perspective. Am Heart J 138 (1999) 307-316
2. THE RESTORE Study Group. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96 (1997) 1445-1453
3. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 338 (1998) 1488-1497
4. Servoss S.J., Wan Y., Snapinn S.M., et al. Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. Am J Cardiol 93 (2004) 843-847
5. Waters D.D., Walling A., Roy D., and Theroux P. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol 58 (1986) 465-469
6. Wiseman A., Waters D.D., Walling A., Pelletier G.B., Roy D., and Theroux P. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. JAMA 12 (1988) 873-880
7. Kleiman N.S., Anderson H.V., Rogers W.J., Theroux P., Thompson B., and Stone P.H. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without coronary artery bypass grafting. Am J Cardiol 77 (1996) 227-231
8. Labinaz M., Sketch Jr. M.H., Ellis S.G., et al. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J 141 (2001) 469-477
9. Labinaz M., Kilaru R., Pieper K., et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using Integrilin therapy (PURSUIT) trial. Circulation 105 (2002) 322-327
10. Bizarri F., Scoletta S., Tucci E., et al. Perioperative use of tirofiban hydrochloride does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 122 (2001) 1181-1185
11. Cheng D.K., Jackevicius C.A., Seidelin P., Feindel C., and Rouleau J.L. Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery. Can J Cardiol 20 (2004) 223-228
12. Shanmugam G. Tirofiban and emergency coronary surgery. Eur J Cardiothorac Surg 28 (2005) 546-550
13. Litmathe J., Boeken U., Feindt P., and Gams E. Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg 51 (2003) 17-21